The Patent Finder

Terms ending in 2032

3-D Matrix, Ltd.

Every in-force patent on 3-D Matrix, Ltd.'s record whose computed term ends in 2032, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,905,708Microrna-Based Methods and Assays for Osteocarcinoma
In force
 · High confidence
3-D Matrix, Ltd.In forceHigh confidence
US 11,260,072MicroRNA-based methods and assays for osteocarcinoma
In force
 · High confidence
3-D Matrix, Ltd.In forceHigh confidence
US 9,322,016MicroRNA-Based Methods and Assays for Osteosarcoma
In force
 · High confidence
3-D Matrix, Ltd.In forceHigh confidence
3 of 3 patents shown. Soonest term end first, then patent number.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited